Tech Company Financing Transactions
Nativis Funding Round
Nativis closed a $9.2 million financing round on 2/12/2014. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/12/2014
Transaction Type
Venture Equity
Amount
$9,161,414
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Not an offer or solicitation for sale of securities. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
24 Roy St. 437
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Not Recorded
Overview
Natvis Voyager is a medical device that replaces standard chemotherapy with specific low level radio frequency energy (REF).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Rivera
Chief Scientific Officer
Kenneth Ferguson
VP - Bus. Development
Xavier Figueroa
VP - Bus. Development
Michael Mischke-Reeds
VP - General Counsel
Steven Pope
VP - Regulatory Affairs
Donna Murray
Browse more venture capital transactions:
Prev: 2/12/2014: Bislr venture capital transaction
Next: 2/12/2014: Bluefly venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs